CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Stocks to watch: These small-cap stocks will be in focus on Thursday!
Kaustubh Bhosale
/ Categories: Trending, Mindshare

Stocks to watch: These small-cap stocks will be in focus on Thursday!

The Nifty 50 index traded near the flat line for the majority of the session.

The benchmark equity indices saw a choppy trading session on Wednesday before finishing with modest losses. The Nifty 50 index traded near the flat line for the majority of the session. However, despite certain index majors remaining firm, the tone was mostly optimistic. After last week's significant upward movement, the sectors of auto, oil & gas and some PSU banks climbed while the sectors of pharmaceuticals and FMCG remained muted.  

  

The following Small-Cap stocks are likely to be in focus on Thursday, December 29, 2022:  

  

Strides Pharma Science: Stelis Biopharma, an emerging biopharmaceutical Contract Development and Manufacturing Organization (CDMO) and the biologics arm of Strides Pharma Science Limited announced that its CDMO partner has received approval for a key ANDA from the United States Food & Drug Administration (USFDA). The filing for the product was done from Stelis Biopharma’s flagship facility in Bangalore.  

  

Hester Biosciences: Hester has signed an agreement towards receiving indigenously developed technology from Indian Council of Agricultural Research - National Institute of High Security Animal Diseases (ICAR-NIHSAD), for the development and commercialization of the Low Pathogenic Avian Influenza (H9N2 strain) Inactivated Vaccine for poultry.   

  

52-week high:  Capri Global Capital, Hariom Pipe Industries, Kirloskar Ferrous Industries, Kovai Medical Center & Hospital and Arvind SmartSpaces.  

  

Keep an eye out for the above-listed small-cap stocks on December 29, 2022. 

Previous Article Days Movers: These stocks were among the top gainers on December 28
Next Article Bulk deals happened in this multibagger penny stock in just one day; check it out!
Print
747 Rate this article:
3.8
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR